About 3 results found for searched term "PA-824" (0.127 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2163 | PA-824 | Anti-infection |
| Pretomanid; (S)-PA 824 | ||
| PA-824 is a novel, orally active nitroimidazole derivative with antimycobacterial activity for use in tuberculosis-related studies. | ||
| M28070 | TBA-354 | Antibiotic |
| TBA-354 is a potent anti-tuberculosis compound. TBA-354 maintains activity against Mycobacterium tuberculosis H37Rv isogenic monoresistant strains and clinical drug-sensitive and drug-resistant isolates. TBA-354 is 5 to 10 times more potent than PA-824, but selected mutants are cross-resistant to PA-824 and delamanid. | ||
| M29003 | Olacaftor | CFTR |
| VX-440 | ||
| Olacaftor (VX-440) is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator extracted from patent US9782408. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
